Mark Massaro
Stock Analyst at BTIG
(4.46)
# 312
Out of 5,124 analysts
176
Total ratings
52.87%
Success rate
20.1%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDXH MDxHealth | Reiterates: Buy | $7 | $3.57 | +96.08% | 10 | Dec 23, 2025 | |
| GH Guardant Health | Maintains: Buy | $100 → $140 | $102.14 | +37.07% | 7 | Dec 12, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $165 → $200 | $130.06 | +53.78% | 7 | Dec 12, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $38 → $50 | $38.90 | +28.53% | 6 | Dec 12, 2025 | |
| BLLN BillionToOne | Reiterates: Buy | $160 | $81.84 | +95.50% | 2 | Dec 10, 2025 | |
| NTRA Natera | Maintains: Buy | $230 → $260 | $229.09 | +13.49% | 16 | Dec 5, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $160 | $125.82 | +27.17% | 4 | Dec 3, 2025 | |
| TEM Tempus AI | Maintains: Buy | $96 → $105 | $59.05 | +77.82% | 6 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Neutral | n/a | $101.56 | - | 20 | Nov 20, 2025 | |
| PSNL Personalis | Maintains: Buy | $11 → $12 | $7.96 | +50.75% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $6.10 | +145.90% | 5 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $4.67 | +49.89% | 3 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $18.84 | +32.70% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $21 | $16.24 | +29.31% | 7 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $785 → $830 | $676.53 | +22.68% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.09 | +129.36% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $8.31 | +8.30% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.55 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.53 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $11.76 | +78.57% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.80 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.06 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $131.16 | +128.73% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $74.49 | -32.88% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $173.53 | -35.46% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $250.88 | -34.23% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $28.56 | +180.11% | 9 | Sep 10, 2018 |
MDxHealth
Dec 23, 2025
Reiterates: Buy
Price Target: $7
Current: $3.57
Upside: +96.08%
Guardant Health
Dec 12, 2025
Maintains: Buy
Price Target: $100 → $140
Current: $102.14
Upside: +37.07%
GeneDx Holdings
Dec 12, 2025
Maintains: Buy
Price Target: $165 → $200
Current: $130.06
Upside: +53.78%
Castle Biosciences
Dec 12, 2025
Maintains: Buy
Price Target: $38 → $50
Current: $38.90
Upside: +28.53%
BillionToOne
Dec 10, 2025
Reiterates: Buy
Price Target: $160
Current: $81.84
Upside: +95.50%
Natera
Dec 5, 2025
Maintains: Buy
Price Target: $230 → $260
Current: $229.09
Upside: +13.49%
Zoetis
Dec 3, 2025
Reiterates: Buy
Price Target: $160
Current: $125.82
Upside: +27.17%
Tempus AI
Nov 25, 2025
Maintains: Buy
Price Target: $96 → $105
Current: $59.05
Upside: +77.82%
Exact Sciences
Nov 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $101.56
Upside: -
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $7.96
Upside: +50.75%
Nov 10, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $6.10
Upside: +145.90%
Nov 10, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $4.67
Upside: +49.89%
Nov 6, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $18.84
Upside: +32.70%
Nov 6, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $16.24
Upside: +29.31%
Nov 4, 2025
Maintains: Buy
Price Target: $785 → $830
Current: $676.53
Upside: +22.68%
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.09
Upside: +129.36%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $8.31
Upside: +8.30%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.55
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.53
Upside: -
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $11.76
Upside: +78.57%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $3.80
Upside: -
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.06
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $131.16
Upside: +128.73%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $74.49
Upside: -32.88%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $173.53
Upside: -35.46%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $250.88
Upside: -34.23%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $28.56
Upside: +180.11%